Published in J Nerv Ment Dis on May 01, 2015
Potential Effects of the Choice of Costing Perspective on Cost Estimates: An Example Based on 6 Early Psychosis Intervention Programs. Can J Psychiatry (2016) 1.39
Empirical evidence about recovery and mental health. BMC Psychiatry (2015) 0.80
Suicide in the Early Stage of Schizophrenia. Front Psychiatry (2016) 0.77
Predictors of long term use of psychiatric services of patients with recent-onset schizophrenia: 12 years follow-up. BMC Psychiatry (2017) 0.75
Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review. Neurol Ther (2016) 0.75
Do Family Interventions Improve Outcomes in Early Psychosis? A Systematic Review and Meta-Analysis. Front Psychol (2017) 0.75
Patterns of illness and care over the 5 years following onset of psychosis in different ethnic groups; the GAP-5 study. Soc Psychiatry Psychiatr Epidemiol (2017) 0.75
A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry (2007) 7.49
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet (2009) 7.45
Choosing a future for epidemiology: II. From black box to Chinese boxes and eco-epidemiology. Am J Public Health (1996) 7.44
Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry (2005) 6.27
One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry (1994) 5.29
Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders. Br J Psychiatry (2011) 4.21
Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry (2001) 4.13
The reversal of fortunes: trends in county mortality and cross-county mortality disparities in the United States. PLoS Med (2008) 3.73
Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry (2006) 3.35
Schizophrenia, neuroleptic medication and mortality. Br J Psychiatry (2006) 3.10
Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychol Med (2006) 2.79
The clinician's illusion. Arch Gen Psychiatry (1984) 2.55
Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry (2004) 2.45
Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry (2013) 2.03
Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull (1998) 1.99
Ten-year course of schizophrenia--the Madras longitudinal study. Acta Psychiatr Scand (1994) 1.85
Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study. Psychol Med (2014) 1.73
Avoidable mortality in people with schizophrenia or bipolar disorder in England. Acta Psychiatr Scand (2012) 1.68
Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study. Schizophr Bull (2005) 1.66
Excess early mortality in schizophrenia. Annu Rev Clin Psychol (2013) 1.47
Recovery as the new medical model for psychiatry. Psychiatr Serv (2012) 1.46
Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophr Bull (1980) 1.45
Long-term follow-up of schizophrenia in 16 countries. A description of the International Study of Schizophrenia conducted by the World Health Organization. Soc Psychiatry Psychiatr Epidemiol (1996) 1.44
First episode psychosis and ethnicity: initial findings from the AESOP study. World Psychiatry (2006) 1.39
Influence of antipsychotics on mortality in schizophrenia: systematic review. Schizophr Res (2009) 1.36
Cumulative social disadvantage, ethnicity and first-episode psychosis: a case-control study. Psychol Med (2008) 1.32
The diagnostic concept of schizophrenia: its history, evolution, and future prospects. Dialogues Clin Neurosci (2010) 1.24
Duration of untreated psychosis and ethnicity in the AESOP first-onset psychosis study. Psychol Med (2005) 1.09
Mortality in first-contact psychosis patients in the U.K.: a cohort study. Psychol Med (2011) 1.04
The prevention of schizophrenia--what can we learn from eco-epidemiology? Schizophr Bull (2010) 1.02
Mortality in chronic schizophrenia during decreasing number of psychiatric beds in Finland. Schizophr Res (2002) 1.01
Increasing mortality gap for patients diagnosed with schizophrenia over the last three decades--a Danish nationwide study from 1980 to 2010. Schizophr Res (2013) 1.01
The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity. Eur Arch Psychiatry Clin Neurosci (2010) 0.98
Suicide prevention in first episode psychosis: the development of a randomised controlled trial of cognitive therapy for acutely suicidal patients with early psychosis. Aust N Z J Psychiatry (2003) 0.97
Predictors of 10-year outcome of first-episode psychosis. Psychol Med (2009) 0.97
Five-year mortality of Finnish schizophrenia patients in the era of deinstitutionalization. Soc Psychiatry Psychiatr Epidemiol (2008) 0.92
Suicide in schizophrenia: findings from a national clinical survey. J Psychiatr Pract (2006) 0.92
Mortality in schizophrenia and other psychoses: a 10-year follow-up of the ӔSOP first-episode cohort. Schizophr Bull (2014) 0.91
Reassessing the long-term risk of suicide after a first episode of psychosis. Arch Gen Psychiatry (2010) 0.90
A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications. J Psychopharmacol (2012) 0.87
Follow-up studies of schizophrenia I: Natural history and non-psychopathological predictors of outcome. Eur Psychiatry (1997) 0.85
The Sydney Mental Health Client Mortality Audit: what does it tell us and what are we to do? Australas Psychiatry (2014) 0.76
HEART--the Hounslow Early Active Recovery Team: implementing an inclusive strength-based model of care for people with early psychosis. J Psychiatr Ment Health Nurs (2009) 0.76
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry (2006) 9.44
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry (2004) 5.95
Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry (2005) 5.57
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet (2003) 4.84
Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet (2012) 4.05
Ethnic density as a buffer for psychotic experiences: findings from a national survey (EMPIRIC). Br J Psychiatry (2012) 4.05
Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry (2002) 4.03
A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry (2002) 3.95
Why psychiatry can't afford to be neurophobic. Br J Psychiatry (2009) 3.80
Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry (2009) 3.67
Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry (2002) 3.59
Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry (2006) 3.35
Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. Am J Psychiatry (2010) 3.05
Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet (2011) 2.99
Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychol Med (2006) 2.79
Symmetries in human brain language pathways correlate with verbal recall. Proc Natl Acad Sci U S A (2007) 2.78
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull (2006) 2.71
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ (2012) 2.70
Outcomes of conduct problems in adolescence: 40 year follow-up of national cohort. BMJ (2009) 2.47
Prevalence and correlates of self-reported psychotic symptoms in the British population. Br J Psychiatry (2004) 2.44
Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs. Br J Psychiatry (2012) 2.41
High-potency cannabis and the risk of psychosis. Br J Psychiatry (2009) 2.41
Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry (2011) 2.37
Disease-relevant autoantibodies in first episode schizophrenia. J Neurol (2010) 2.33
Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses. PLoS One (2012) 2.33
Supported employment: randomised controlled trial. Br J Psychiatry (2010) 2.32
Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res (2004) 2.30
Barriers and facilitators of disclosures of domestic violence by mental health service users: qualitative study. Br J Psychiatry (2010) 2.27
Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction (2007) 2.20
Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry (2013) 2.17
Schizophrenia in the offspring of antenatally depressed mothers in the northern Finland 1966 birth cohort: relationship to family history of psychosis. Am J Psychiatry (2009) 2.11
A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophr Res (2011) 2.09
Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study. Br J Psychiatry (2011) 2.06
Phenomenology, science and the anthropology of the self: a new model for the aetiology of psychosis. Br J Psychiatry (2004) 2.03
Adolescents who were born very preterm have decreased brain volumes. Brain (2002) 1.97
Raised incidence rates of all psychoses among migrant groups: findings from the East London first episode psychosis study. Arch Gen Psychiatry (2008) 1.96
Temporal course of auditory hallucinations. Br J Psychiatry (2004) 1.95
Reliability and comparability of psychosis patients' retrospective reports of childhood abuse. Schizophr Bull (2009) 1.94
Grey and white matter distribution in very preterm adolescents mediates neurodevelopmental outcome. Brain (2007) 1.91
Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry (2004) 1.87
Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder: computational morphometry study. Br J Psychiatry (2005) 1.83
Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry (2006) 1.81
Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology (2005) 1.76
Self-harm in first-episode psychosis. Br J Psychiatry (2008) 1.72
Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry (2007) 1.71
A diffusion tensor imaging study of fasciculi in schizophrenia. Am J Psychiatry (2007) 1.71
Pituitary volume in psychosis. Br J Psychiatry (2004) 1.70
Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry (2008) 1.70
Life events and psychosis: a review and meta-analysis. Schizophr Bull (2013) 1.70
Infant developmental milestones and subsequent cognitive function. Ann Neurol (2007) 1.69
Developmental typology of trajectories to nighttime bladder control: epidemiologic application of longitudinal latent class analysis. Am J Epidemiol (2003) 1.65
Parental separation, loss and psychosis in different ethnic groups: a case-control study. Psychol Med (2007) 1.64
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. Biol Psychiatry (2012) 1.64
Psychosis and place. Epidemiol Rev (2008) 1.63
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology (2009) 1.62
Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol Psychiatry (2010) 1.60
Neurocognitive deficits in first-episode schizophrenic patients and their first-degree relatives. Am J Med Genet B Neuropsychiatr Genet (2007) 1.59
Pathways to schizophrenia: the impact of environmental factors. Int J Neuropsychopharmacol (2004) 1.58
Migration, ethnicity, and psychosis: toward a sociodevelopmental model. Schizophr Bull (2010) 1.58
Randomized trial of a parenting intervention for very preterm infants: outcome at 2 years. J Pediatr (2009) 1.55
Corpus callosum size and very preterm birth: relationship to neuropsychological outcome. Brain (2004) 1.55